CN111018824A - Method for synthesizing 4, 5-dimethyl-1, 3-dioxol-2-one - Google Patents

Method for synthesizing 4, 5-dimethyl-1, 3-dioxol-2-one Download PDF

Info

Publication number
CN111018824A
CN111018824A CN201911254084.0A CN201911254084A CN111018824A CN 111018824 A CN111018824 A CN 111018824A CN 201911254084 A CN201911254084 A CN 201911254084A CN 111018824 A CN111018824 A CN 111018824A
Authority
CN
China
Prior art keywords
dimethyl
dioxol
dichloro
follows
synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201911254084.0A
Other languages
Chinese (zh)
Inventor
邢领俊
安娜
龙中柱
蔡畅
蔡水洪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Dongyue Pharmaceutical Co Ltd
Original Assignee
Shanghai Dongyue Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Dongyue Pharmaceutical Co Ltd filed Critical Shanghai Dongyue Pharmaceutical Co Ltd
Priority to CN201911254084.0A priority Critical patent/CN111018824A/en
Publication of CN111018824A publication Critical patent/CN111018824A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D317/34Oxygen atoms
    • C07D317/40Vinylene carbonate; Substituted vinylene carbonates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a method for synthesizing 4, 5-dimethyl-1, 3-dioxole-2-ketone, which comprises the following steps: the method comprises the following steps: cyclizing 2, 3-butanedione and triphosgene to obtain 4, 5-dichloro-4, 5-dimethyl-1, 3-dioxolane-2-one; step two: dechlorinating 4, 5-dichloro-4, 5-dimethyl-1, 3-dioxol-2-one under the action of a reducing agent to prepare 4, 5-dimethyl-1, 3-dioxol-2-one. The method has mild conditions, and is simple and efficient.

Description

Method for synthesizing 4, 5-dimethyl-1, 3-dioxol-2-one
Technical Field
The invention relates to a new process for preparing 4, 5-dimethyl-1, 3-dioxol-2-one by using 2, 3-butanedione as a raw material.
Background
4, 5-dimethyl-1, 3-dioxol-2-one is an important pharmaceutical intermediate, and has been used in the synthesis of various drugs, such as olmesartan, quinolone antibacterial prulifloxacin, penicillin antibiotic, and penicillin.
The traditional process is to prepare 4, 5-dimethyl-1, 3-dioxol-2-one by taking 3-hydroxy-2-butanone and triphosgene as raw materials through the steps of acylation, cyclization, dehydrochlorination and the like.
Figure BDA0002309818050000011
Disclosure of Invention
The invention aims to provide a method for synthesizing 4, 5-dimethyl-1, 3-dioxol-2-one under mild conditions, simply and efficiently.
The technical solution of the invention is as follows:
a method of synthesizing 4, 5-dimethyl-1, 3-dioxol-2-one, the method comprising the steps of:
Figure BDA0002309818050000012
the method comprises the following steps: cyclizing 2, 3-butanedione and triphosgene to obtain 4, 5-dichloro-4, 5-dimethyl-1, 3-dioxolane-2-one;
step two: dechlorinating 4, 5-dichloro-4, 5-dimethyl-1, 3-dioxol-2-one under the action of a reducing agent to prepare 4, 5-dimethyl-1, 3-dioxol-2-one.
The operation of the first step is as follows: slowly dripping a dichloromethane solution of pyridine and triphosgene into a dichloromethane solution of 2, 3-butanedione at 0-30 ℃, stirring for 2-8 h, adding water for quenching reaction, extracting for phase separation, back extracting the water phase once by using dichloromethane, combining organic phases, and concentrating to obtain 4, 5-dichloro-4, 5-dimethyl-1, 3-dioxolane-2-one.
The molar ratio of the 2, 3-butanedione to the pyridine to the triphosgene is as follows: 1:0.5:0.4.
The operation of the second step is as follows: adding a reducing reagent into the solution of 4, 5-dichloro-4, 5-dimethyl-1, 3-dioxol-2-one in batches at the temperature of 20-80 ℃, stirring and reacting for 2-8 h, filtering after the reaction is finished, concentrating the filtrate, adding water, stirring and crystallizing, and filtering to obtain 4, 5-dimethyl-1, 3-dioxol-2-one.
Wherein the reducing reagent is zinc powder, iron powder, copper-zinc alloy and other reducing reagents; the solution is water, ethers, alkanes, aromatics, alcohols, acids, anhydrides, polar aprotic solutions and mixed solutions thereof, such as glycol dimethyl ether, n-heptane, toluene, ethanol, acetic acid, acetic anhydride, DMF and the like and mixed solutions thereof.
The molar ratio of the 4, 5-dichloro-4, 5-dimethyl-1, 3-dioxolane-2-one to the reducing agent is as follows: 1: (1-10).
The method has mild conditions, and is simple and efficient.
The present invention will be further described with reference to the following examples.
Detailed Description
Example 1
Slowly adding pyridine (4g) and triphosgene (11.8g) in dichloromethane (36mL) into 2, 3-butanedione (8.6g) at 10-20 ℃, stirring for 3h, adding water (50mL) to quench the reaction, extracting and separating phases, back-extracting the aqueous phase once with dichloromethane (50mL), combining organic phases, and concentrating to obtain 14.8g of 4, 5-dichloro-4, 5-dimethyl-1, 3-dioxolane-2-one with the yield of 80%.
Example 2
Adding zinc powder (7.8g) in batches into a solution of 4, 5-dichloro-4, 5-dimethyl-1, 3-dioxolane-2-one (7.4g) in ethanol (15mL) and acetic acid (15mL) at 40-50 ℃, and reacting for 4 hours at 60-70 ℃. After the reaction, the mixture is filtered, the filtrate is concentrated, 15mL of water is added, the mixture is stirred and crystallized, and 3.6g of 4, 5-dimethyl-1, 3-dioxol-2-one is obtained by filtration, and the yield is 79%.
Example 3
Adding zinc powder (9.1g) in batches into a toluene (15mL) and acetic anhydride (15mL) solution of 4, 5-dichloro-4, 5-dimethyl-1, 3-dioxolan-2-one (7.4g) at 30-40 ℃, and reacting for 6h at 70-80 ℃. After the reaction, the mixture was filtered, the filtrate was concentrated, 15mL of water was added, followed by crystallization with stirring and filtration to obtain 3.8g of 4, 5-dimethyl-1, 3-dioxol-2-one with a yield of 83%.

Claims (6)

1. A method for synthesizing 4, 5-dimethyl-1, 3-dioxol-2-one is characterized by comprising the following steps: the reaction formula is as follows:
Figure FDA0002309818040000011
the method comprises the following steps:
the method comprises the following steps: cyclizing 2, 3-butanedione and triphosgene to obtain 4, 5-dichloro-4, 5-dimethyl-1, 3-dioxolane-2-one;
step two: dechlorinating 4, 5-dichloro-4, 5-dimethyl-1, 3-dioxol-2-one under the action of a reducing agent to prepare 4, 5-dimethyl-1, 3-dioxol-2-one.
2. The method of claim 1, wherein the synthesis of 4, 5-dimethyl-1, 3-dioxol-2-one comprises: and in the second step, the reducing reagent is zinc powder, iron powder or a copper-zinc alloy agent.
3. The method of claim 1, wherein the synthesis of 4, 5-dimethyl-1, 3-dioxol-2-one comprises: the operation of the step one is as follows: slowly dripping a dichloromethane solution of pyridine and triphosgene into a dichloromethane solution of 2, 3-butanedione at 0-30 ℃, stirring for 2-8 h, adding water for quenching reaction, extracting for phase separation, back extracting the water phase once by using dichloromethane, combining organic phases, and concentrating to obtain 4, 5-dichloro-4, 5-dimethyl-1, 3-dioxolane-2-one.
4. The method of claim 3, wherein the synthesis of 4, 5-dimethyl-1, 3-dioxol-2-one comprises: the molar ratio of the 2, 3-butanedione to the pyridine to the triphosgene is as follows: 1:0.5:0.4.
5. The method of claim 1, wherein the synthesis of 4, 5-dimethyl-1, 3-dioxol-2-one comprises: the operation of the second step is as follows: adding a reducing reagent into the solution of 4, 5-dichloro-4, 5-dimethyl-1, 3-dioxol-2-one in batches at the temperature of 20-80 ℃, stirring and reacting for 2-8 h, filtering after the reaction is finished, concentrating the filtrate, adding water, stirring and crystallizing, and filtering to obtain 4, 5-dimethyl-1, 3-dioxol-2-one.
6. The method of claim 5, wherein the synthesis of 4, 5-dimethyl-1, 3-dioxol-2-one comprises: the molar ratio of the 4, 5-dichloro-4, 5-dimethyl-1, 3-dioxolane-2-one to the reducing agent is as follows: 1: (1-10).
CN201911254084.0A 2019-12-10 2019-12-10 Method for synthesizing 4, 5-dimethyl-1, 3-dioxol-2-one Withdrawn CN111018824A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911254084.0A CN111018824A (en) 2019-12-10 2019-12-10 Method for synthesizing 4, 5-dimethyl-1, 3-dioxol-2-one

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911254084.0A CN111018824A (en) 2019-12-10 2019-12-10 Method for synthesizing 4, 5-dimethyl-1, 3-dioxol-2-one

Publications (1)

Publication Number Publication Date
CN111018824A true CN111018824A (en) 2020-04-17

Family

ID=70208313

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911254084.0A Withdrawn CN111018824A (en) 2019-12-10 2019-12-10 Method for synthesizing 4, 5-dimethyl-1, 3-dioxol-2-one

Country Status (1)

Country Link
CN (1) CN111018824A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112480061A (en) * 2020-12-27 2021-03-12 江苏瀚康新材料有限公司 Method for preparing vinylene carbonate by using waste
CN115819394A (en) * 2022-11-28 2023-03-21 江苏恒盛药业有限公司 Synthesis process for preparing vinylene carbonate by using monochloroethylene carbonate byproduct

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112480061A (en) * 2020-12-27 2021-03-12 江苏瀚康新材料有限公司 Method for preparing vinylene carbonate by using waste
CN115819394A (en) * 2022-11-28 2023-03-21 江苏恒盛药业有限公司 Synthesis process for preparing vinylene carbonate by using monochloroethylene carbonate byproduct

Similar Documents

Publication Publication Date Title
CN108129288B (en) Synthesis method of trans-3-hydroxycyclobutylformic acid
HRP20010514A2 (en) Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament
CN112608296B (en) Synthesis method of Brazilane natural product Brazilane
CN111018824A (en) Method for synthesizing 4, 5-dimethyl-1, 3-dioxol-2-one
CN101337966B (en) Method for preparing high-purity irinotecan
CN108840814B (en) Preparation method of 8-oxo-2, 6, 9-triazaspiro [4.5] decane-2-carboxylic acid tert-butyl ester
CN108314647B (en) Preparation method of quinoline-2-formic acid and quinoline-2-formic acid derivative
CN113278021B (en) Preparation method of 1, 7-diazaspiro [3.5] nonane-7-tert-butyl formate and oxalate thereof
Guo et al. Concise synthesis of the tricyclic skeleton of crotobarin and crotogoudin via a gold-catalyzed cycloisomerization reaction
CN109851599B (en) Preparation method of 2-aminobenzofuran compound
CN111747926B (en) Improved synthetic process method of topiramate free base
CN113402476A (en) Imine oxazine derivative and preparation method thereof
CN108299466B (en) Improved dolutegravir synthesis method
CN110563721A (en) Preparation method of azasetron hydrochloride
CN111592553A (en) Method for preparing moxidectin
CN101880285B (en) Method for synthetizing allyl-substituted camptothecin compound
JP2006193444A (en) Method for producing 4,4'-dicarboxy-2,2'-bipyridine
CN105418507A (en) Preparation method for 1-(3-methyl-1-phenyl-1H-pyrazole-5-yl)piperazine
CN104262265B (en) A kind of preparation method of tetrahydro quinazoline derivative
WO2016147104A1 (en) Novel process for the preparation of perampanel and its intermediates thereof
CN114195820B (en) Isoserine derivative, preparation thereof and application thereof in taxol synthesis
CN108997340B (en) Synthetic method of 5-bromo-7-azaindole
CN110294715B (en) Synthesis method of 2,4, 6-trichloro-5-methoxypyrimidine
CN117247349A (en) Quinoline oxynitride C 2 Process for the dithiocarbamation of H
DE60225270T2 (en) PROCESS FOR THE PRODUCTION OF ISOFLAVONES

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20200417

WW01 Invention patent application withdrawn after publication